Treatment of bleeding after kidney biopsy with recombinant activated factor VII

Maksimović, Bojana; Neretljak, Ivan; Vidas, Željko; Vojtušek, Ivana Kovačević; Tomulić, Katarina; Knotek, Mladen

doi:10.1097/mbc.0b013e32835029a5

Search citation statements

Order By: Relevance

Paper Sections

Select...

Avf1

Measures That Related To Minimizing the Bleeding Complications1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2021

Publication Types

Select...

Book4

Article2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 9 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In rare cases AVF can cause the development of an aneurysm, which may manifest clinically with high performing embolization of a pseudoaneurysm or surgery to stop the bleeding, we can resort to offlabel drug use such as recombinant activated factor Ⅶ [30] .…”

Section: Avfmentioning

confidence: 99%

Renal biopsy: Still a landmark for the nephrologist

Visconti

Cernaro

Ricciardi

et al. 2016

WJN

View full text Add to dashboard Cite

show abstract

Section: Avfmentioning

confidence: 99%

Renal biopsy: Still a landmark for the nephrologist

Visconti

Cernaro

Ricciardi

et al. 2016

WJN

View full text Add to dashboard Cite

show abstract

“…In the case report of Maksimovic et al [19], recombinant activated factor VII (rFVIIa) was used to treat uncontrolled bleeding which was caused by renal biopsy after unsuccessful treatment with desmopressin. With the application of rFVIIa, the bleeding stopped immediately.…”

Section: Measures That Related To Minimizing the Bleeding Complicationsmentioning

confidence: 99%

Factors that can minimize bleeding complications after renal biopsy

Zhu

Chen

2014

Int Urol Nephrol

View full text Add to dashboard Cite

Renal biopsy is a very important diagnostic tool in the evaluation of renal diseases. However, bleeding remains to be one of the most serious complications in this procedure. Many new techniques have been improved to make it safer. The risk factors and predictors of bleeding after percutaneous renal biopsy have been extensively reported in many literatures, and generally speaking, the common risk factors for renal biopsy complications focus on hypertension, high serum creatinine, bleeding diatheses, amyloidosis, advanced age, gender and so on. Our primary purpose of this review is to summarize current measures in recent years literature aiming at minimizing the bleeding complication after the renal biopsy, including the drug application before and after renal biopsy, operation details in percutaneous renal biopsies, nursing and close monitoring after the biopsy and other kinds of biopsy methods.

show abstract

Bleeding in Uremia

Lutz¹,

Weinmann‐Menke

2021

Management of Bleeding Patients

View full text Add to dashboard Cite

Treatment of bleeding after kidney biopsy with recombinant activated factor VII

Cited by 9 publications

References 17 publications

Renal biopsy: Still a landmark for the nephrologist

Renal biopsy: Still a landmark for the nephrologist

Factors that can minimize bleeding complications after renal biopsy

Bleeding in Uremia

Contact Info

Product

Resources

About